Kohana Pharmacy and Center for Regenerative Medicine Inc., San Luis Obispo, CA
Is Kohana Pharmacy and Center for Regenerative Medicine Inc. registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Kohana Pharmacy and Center for Regenerative Medicine Inc. hold a California pharmacy license?
No license with this exact name and city was found in the California State Board of Pharmacy file dated Nov 6, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file lists current licenses only, not revoked, surrendered or cancelled ones.
Has Kohana Pharmacy and Center for Regenerative Medicine Inc. had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Nov 22, 2019) and 1 FMD-145 letter (Nov 22, 2019) for Kohana Pharmacy and Center for Regenerative Medicine Inc. State board actions: record found. The California State Board of Pharmacy’s posted disciplinary decisions on facility licenses lists 3 actions: “Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended” dated May 12, 2021, case AC 6922 on license PHY 50264, “Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the license is placed on probation for five years subject to the terms and conditions in the decision” dated Jul 25, 2019, case AC 5556 on license PHY 50264 and “Through a disciplinary action of the Board, the license is voluntarily surrendered” dated Aug 24, 2017, case AC 5556 on license LSC 99609. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Kohana Pharmacy and Center for Regenerative Medicine Inc.
- Location
- San Luis Obispo, CA
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Nov 22, 2019
- FDA Data Dashboard inspections
- No matching site found
- State board records
- No exact match
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Kohana Pharmacy and Center for Regenerative Medicine Inc., a 503A facility, with 3 dated actions.
| Document | |||
|---|---|---|---|
| Nov 22, 2019 | FMD-145 letter | FMD-145 Letter Issued 11/22/2019 | FDA copy (archived) |
| Nov 22, 2019 | State referral letter | Referral Letter to the California State Board of Pharmacy Issued 11/22/2019 | FDA copy (archived) |
| Apr 17, 2019 | Form 483 | 483 Issued 04/17/2019 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 1 Form 483 PDF for Kohana Pharmacy and Center for Regenerative Medicine Inc., but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Apr 17, 2019: FDA document 124963: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
No license with this exact name and city was found in the California State Board of Pharmacy file dated Nov 6, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file lists current licenses only, not revoked, surrendered or cancelled ones. Board file.
Board actions
As the board words them, newest first. An entry that is a complaint, charge or notice the board filed is a charge, not a final decision; only an order or final action records the outcome.
- May 12, 2021: “Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.”, license PHY 50264, case AC 6922, Kohana Pharmacy and Center for Regenerative Medicine, San Luis Obispo, CA. Board list
- Jul 25, 2019: “Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the license is placed on probation for five years subject to the terms and conditions in the decision.”, license PHY 50264, case AC 5556, Kohana Pharmacy and Center for Regenerative Medicine, San Luis Obispo, CA. Board list
- Aug 24, 2017: “Through a disciplinary action of the Board, the license is voluntarily surrendered.”, license LSC 99609, case AC 5556, Kohana Pharmacy and Center for Regenerative Medicine, San Luis Obispo, CA. Board list
What this covers: Facility license decisions from the board’s quarterly Disciplinary Actions pages (87 of 88 quarters had a facility section). These are final decisions; accusations filed and immediate protection orders are not included. Actions in the data are dated Jan 5, 2005 to Oct 28, 2026.
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- California State Board of Pharmacy license file
- California State Board of Pharmacy disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.